Literature DB >> 8074758

The role of the NIH's Office of Research on Women's Health.

V W Pinn1.   

Abstract

The Office of Research on Women's Health (ORWH) at the National Institutes of Health (NIH) was created in 1990 to carry out three major mandates: (1) to strengthen, develop, and increase research into diseases, disorders, and conditions that are unique to, more prevalent among, or more serious in women, or for which there are different risk factors for women than for men; (2) to ensure that women are appropriately represented in biomedical and biobehavioral research studies, especially clinical trials, that are supported by the NIH; and (3) to direct initiatives to increase the number of women in biomedical careers. One of the ORWH's first accomplishments was a 1992 report that serves as a basis for the ORWH's research agenda; its recommendations focus on scientific issues affecting women's health from birth to old age. To implement these recommendations, the ORWH does not fund studies directly but instead provides funds through NIH institutes and centers to augment new research initiatives, to expand ongoing studies to address high-priority areas concerning women's health (14 of which were identified for special consideration in FY 93), and to increase the participation of women in clinical studies. In addition, the ORWH is playing a key advisory role in the NIH's Women's Health Initiative, a long-term study of over 100,000 women to examine the major causes of death, disability, and frailty--heart disease and stroke, breast and colorectal cancers, and osteoporosis--in older women of all races and from all socioeconomic strata.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Keywords:  Biomedical and Behavioral Research; NIH Revitalization Act 1993; National Institutes of Health; Office of Research on Women's Health; Women's Health Initiative

Mesh:

Year:  1994        PMID: 8074758     DOI: 10.1097/00001888-199409000-00003

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  8 in total

1.  Medical students' attitudes toward women: are medical schools microcosms of society?

Authors:  C A Woodward
Journal:  CMAJ       Date:  1999-02-09       Impact factor: 8.262

Review 2.  Why African Americans may not be participating in clinical trials.

Authors:  Y Harris; P B Gorelick; P Samuels; I Bempong
Journal:  J Natl Med Assoc       Date:  1996-10       Impact factor: 1.798

3.  Establishing a community network for recruitment of African Americans into a clinical trial. The African-American antiplatelet stroke Prevention Study (AAASPS) experience.

Authors:  P B Gorelick; D Richardson; E Hudson; C Perry; D Robinson; N Brown; Y Harris
Journal:  J Natl Med Assoc       Date:  1996-11       Impact factor: 1.798

4.  Attitudes and beliefs of African Americans toward participation in medical research.

Authors:  G Corbie-Smith; S B Thomas; M V Williams; S Moody-Ayers
Journal:  J Gen Intern Med       Date:  1999-09       Impact factor: 5.128

5.  The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. An interim report from the African-American Antiplatelet Stroke Prevention Study (AAASPS).

Authors:  P B Gorelick; Y Harris; B Burnett; F J Bonecutter
Journal:  J Natl Med Assoc       Date:  1998-03       Impact factor: 1.798

Review 6.  Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy.

Authors:  D M Rabi; N Khan; M Vallee; M A Hladunewich; S W Tobe; L Pilote
Journal:  Can J Cardiol       Date:  2008-06       Impact factor: 5.223

7.  Participation of women and sex analyses in late-phase clinical trials of new molecular entity drugs and biologics approved by the FDA in 2007-2009.

Authors:  Rita Poon; Keshav Khanijow; Sphoorti Umarjee; Emmanuel Fadiran; Monica Yu; Lei Zhang; Ameeta Parekh
Journal:  J Womens Health (Larchmt)       Date:  2013-06-14       Impact factor: 2.681

Review 8.  The impact of sex and gender on immunotherapy outcomes.

Authors:  Sabra L Klein; Rosemary Morgan
Journal:  Biol Sex Differ       Date:  2020-05-04       Impact factor: 5.027

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.